Cancer survivors may experience more challenges to adopt a child
the ONA take:
According to a recent study published online ahead of print in the journal Cancer, researchers have found that cancer survivors' options for adoption may be limited by adoption agencies' policies.
Many young cancer survivors often opt to adopt to a child after cancer and cancer therapies leave some patients infertile; however, not only is adoption a long and costly process, but some adoption agencies also have policies that may prevent cancer survivors from being able to adopt.
For the study, oncology nurses participating in a training program contacted and interviewed adoption agencies about the costs and requirements for adoption. the nurses found that adoption fees ranged from $3,000 to $75,000. They also found that a few agencies believed it could be discouraging for a birth mother to have an adoptive parent with a history of cancer, while others reported that a history of cancer could make birth mothers feel optimistic and confident.
The study also helped oncology nurses to become more knowledgeable about the challenges of adoption in cancer survivors, and study authors hope that this experience will help them to better inform their patients on parenthood options in the future.
Researchers have found that cancer survivors' options for adoption may be limited by adoption agencies' policies.
- Physical Activity Improves Outcomes for Patients with Breast Cancer and Survivors
- Behavior Pain Assessment Tool Measures Pain In Patients Who Cannot Communicate Verbally
- Whole Genome Sequencing Reveals that 12% of Childhood Cancer Survivors Have Mutations in Genes that Increase Cancer Risk
- Increased 5-Year Survival Rate Seen in NSCLC Subset Treated With Nivolumab
- Novel Test For Multiple Myeloma Uses Microchip, Conventional Blood Sample
- Exercise, Psychological Interventions Better for Cancer Fatigue Than Medications
- ASCO Issues Global Guidance for HPV Vaccination for Cervical Cancer Prevention
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Little Opposition to Early Palliative Care for Symptom Management in Pediatric Oncology
- Updated ASTRO Guideline Bolsters Safety, Efficacy of Palliative RT for Bone Metastases
- Thyroid Cancer Incidence Increasing Among Younger, Hispanic, African American Populations
- JAK1, JAK2 Inhibition Improves Outcomes in Myeloproliferative Neoplasms, But More Is Needed
- Recommendations Against Contralateral Prophylactic Mastectomy Not Tied to Patient Satisfaction
- Self-efficacy Level Predictive of Likelihood to Follow Through With Colorectal Cancer Screening
- Chronic Myeloproliferative Neoplasms Treatment (Fact Sheet)
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|